News from Visiopharm

Webinar - AI Deep Learning

November 13th, 2018

13:00-14:00 CEST, 7:00-8:00 AM EDT, 4:00-5:00 AM PDT
Sign up here

18:00-19:00 CEST, 12:00-1:00 PM EDT, 9:00-10:00 AM PDT
Sign up here


Fluidigm Announces Co-Marketing Agreement with Visiopharm

Together with Fluidigm we'll expand and simplify imaging mass cytometry data analysis. 

“The collaboration between Fluidigm and Visiopharm will provide scientists novel tools to understand the biology of cancer, including the phenotyping of cells within the tumor microenvironment,” said Michael Grunkin, CEO of Visiopharm. “Our complementary technologies provide an entirely new research approach to drive drug-diagnostic co-development on a tissue-based platform, with the potential to also provide a new framework for precision medicine in cancer.”

Read press release here


Launching Phenomap: New Automated Phenotyping in High Dimensional Images

Introducing PhenomapTM Multiplexing a novel software tool to streamline and analyze high dimensional multiplex image data. 

PhenomapTM is a streamlined and intuitive workflow for simultaneous analysis of up to 255 channels by automatically identifying individual cells and performing cell-based phenotyping.

Discover how PhenomapTM can help you - read more


New APP: PD-L1, Cell Lines, Cancer

This APP can be used for quality control of PD-L1 strong positive, intermediate positive, weak positive and negative cell line material to ensure that each cell line block complies with the expected PD-L1 expression before the material is used as reference standard for IHC assays. The APP quantifies the PD-L1 expression in each cell line core and relates this expression to a known reference value for each cell line expression level.

For more information visit our APP Center

Sign up to our newsletter
* indicates required
Are you a current customer

Visiopharm quantitative digital pathology solutions provide pathologists and scientists with a flexible, powerful suite of software to quantify relevant tissue properties in a fast, objective and reproducible way.

Learn more about us

Visit our APP center

The world's largest and fastest growing

Visit the complete app center


Visiopharm software is featured in over 1300 international scientific publications. They are based on collaborations with leading scientists in hospitals, biopharmaceutical companies and research institutions around the world. Select a main category to access the publication list.